| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | Mani Mohindru | Chief Executive Officer | Jul 14, 2026 | Buy | $1.46 | 34,364 | 50,000 | 59,067 | Jul 16, 2026, 04:01 PM | |
| CRDF | Cardiff Oncology, Inc. | Mani Mohindru | Chief Executive Officer | Jun 18, 2026 | Buy | $1.21 | 24,703 | 29,891 | 24,703 | Jun 22, 2026, 09:00 AM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Dec 04, 2019 | Sale | $17.05 | 4,755 | 81,073 | 17,441 | Dec 04, 2019, 07:50 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Jul 15, 2019 | Option/RSU Exercise | $14.06 | 37,431 | 526,280 | 51,294 | Jul 17, 2019, 05:46 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Jul 15, 2019 | Sale | $25.00 | 37,431 | 935,775 | 13,863 | Jul 17, 2019, 05:46 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | May 29, 2019 | Sale | $21.39 | 2,496 | 53,389 | 13,863 | May 30, 2019, 06:17 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Mar 13, 2019 | Sale | $19.12 | 16,041 | 306,704 | 8,026 | Mar 15, 2019, 04:42 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Mar 13, 2019 | Option/RSU Exercise | $14.06 | 16,041 | 225,536 | 24,067 | Mar 15, 2019, 04:42 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Dec 28, 2018 | Sale | $12.55 | 4,500 | 56,475 | 8,026 | Jan 02, 2019, 05:54 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Nov 15, 2018 | Option/RSU Exercise | $14.06 | 16,042 | 225,551 | 16,042 | Nov 16, 2018, 04:22 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Nov 15, 2018 | Sale | $18.50 | 16,042 | 296,777 | 0 | Nov 16, 2018, 04:22 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Oct 17, 2018 | Sale | $20.19 | 16,042 | 323,888 | 0 | Oct 19, 2018, 04:32 PM | |
| CARA | Cara Therapeutics, Inc. | Mani Mohindru | CFO & Chief Strategy Officer | Oct 17, 2018 | Option/RSU Exercise | $14.06 | 16,042 | 225,551 | 16,042 | Oct 19, 2018, 04:32 PM |
